These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24595605)

  • 21. Binding of coumarins to site I of human serum albumin. Effect of the fatty acids.
    Zatón AM; Ferrer JM; Ruiz de Gordoa JC; Marquínez MA
    Chem Biol Interact; 1995 Jul; 97(2):169-74. PubMed ID: 7606814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Templated assembly of albumin-based nanoparticles for simultaneous gene silencing and magnetic resonance imaging.
    Mertz D; Affolter-Zbaraszczuk C; Barthès J; Cui J; Caruso F; Baumert TF; Voegel JC; Ogier J; Meyer F
    Nanoscale; 2014 Oct; 6(20):11676-80. PubMed ID: 25163585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions.
    Ascoli GA; Bertucci C; Salvadori P
    Biomed Chromatogr; 1998; 12(5):248-54. PubMed ID: 9787894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
    Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
    Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand binding strategies of human serum albumin: how can the cargo be utilized?
    Varshney A; Sen P; Ahmad E; Rehan M; Subbarao N; Khan RH
    Chirality; 2010 Jan; 22(1):77-87. PubMed ID: 19319989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing the binding site characteristics of HSA: a combined molecular dynamics and cheminformatics investigation.
    Pongprayoon P; Gleeson MP
    J Mol Graph Model; 2014 Nov; 54():164-73. PubMed ID: 25459768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the interaction of human serum albumin with bilirubin in the presence of aspirin by multi-spectroscopic, molecular modeling and zeta potential techniques: insight on binary and ternary systems.
    Hosainzadeh A; Gharanfoli M; Saberi M; Chamani J
    J Biomol Struct Dyn; 2012; 29(5):1013-50. PubMed ID: 22292958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
    Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of albumin on podocytes: the role of the fatty acid moiety and the potential role of CD36 scavenger receptor.
    Pawluczyk IZ; Pervez A; Ghaderi Najafabadi M; Saleem MA; Topham PS
    Exp Cell Res; 2014 Aug; 326(2):251-8. PubMed ID: 24815572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of esterified fatty acids bound to serum albumin purified from human plasma and characterised by MALDI mass spectrometry.
    Belgacem O; Stübiger G; Allmaier G; Buchacher A; Pock K
    Biologicals; 2007 Mar; 35(1):43-9. PubMed ID: 16580227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat-induced conformational unfolding of fatty acid-free and fatted camel serum albumin: a comparative study.
    Farivar F; Moosavi-Movahedi AA; Salami M; Bohlooli M; Niasari-Naslaji A
    Cell Biochem Biophys; 2013 Nov; 67(2):727-34. PubMed ID: 23512227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis.
    Ma Z; Bai J; Wang Y; Jiang X
    ACS Appl Mater Interfaces; 2014 Feb; 6(4):2431-8. PubMed ID: 24460090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detergent binding as a sensor of hydrophobicity and polar interactions in the binding cavities of proteins.
    Peyre V; Lair V; André V; le Maire G; Kragh-Hansen U; le Maire M; Møller JV
    Langmuir; 2005 Sep; 21(19):8865-75. PubMed ID: 16142972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride.
    Zsila F; Fitos I; Bikádi Z; Simonyi M; Jackson HL; Lockwood SF
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5357-66. PubMed ID: 15454227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging interactions of proteins with silica nanoparticles: the influence of pH, ionic strength and protein concentration.
    Bharti B; Meissner J; Klapp SH; Findenegg GH
    Soft Matter; 2014 Feb; 10(5):718-28. PubMed ID: 24835283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
    Zhu L; Yang F; Chen L; Meehan EJ; Huang M
    J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adsorption of serum albumin on silica--the influence of surface cleaning procedures.
    Svensson O; Arnebrant T
    J Colloid Interface Sci; 2010 Apr; 344(1):44-7. PubMed ID: 20116799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-dependent interaction and resultant structures of silica nanoparticles and lysozyme protein.
    Kumar S; Aswal VK; Callow P
    Langmuir; 2014 Feb; 30(6):1588-98. PubMed ID: 24475981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-like Biorecognition Sites for Proteins from Surface Imprinting on Nanoparticles.
    Bhakta S; Seraji MS; Suib SL; Rusling JF
    ACS Appl Mater Interfaces; 2015 Dec; 7(51):28197-206. PubMed ID: 26636440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.